CARL
CARLSMED, INC.
US
Key data
Open—
From 52W high—
Volume—
Market cap—
P/E (TTM)—
P/S (TTM)—
Div yield—
Key data
Open
—
From 52W high
—
Volume
—
Market cap
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
P/E (TTM)
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
Latest newsMore news →
Carlsmed, Inc. appointed Richard Heppenstall as Chief Financial Officer effective September 28, 2026, with a $500,000 base salary and equity awards valued at $1,400,000 each.16d agoCarlsmed, Inc. Chief Financial Officer Leo Greenstein departed effective September 25, 2026, with severance including $500,000 in cash payments and accelerated equity vesting.16d agoCarlsmed, Inc. filed a patent infringement lawsuit against DeGen Medical, Inc. in the United States District Court for the District of South Carolina Florence Division, asserting infringement of eight patents and seeking injunctive relief and damages.31d ago